immunocore
AstraZeneca loses two senior executives as biotechs appoint new CEOs
January 7, 2019Sales and Marketing AstraZeneca, CEO, Ironwood Pharmaceuticals, biotech, immunocore
Two of AstraZeneca’s senior executives have been poached by the biotech firms Ironwood Pharmaceuticals and Immunocore, as the two biotechnology …
Lilly and Immunocore collaborate on melanoma
June 29, 2015Research and Development, Sales and Marketing LY2157299, LY2801653, brett wells, immunocore, lilly
Eli Lilly is teaming up again with UK biotech Immunocore in order to work together on immunotherapy-based clinical trials. Specifically …
AstraZeneca signs immuno-oncology deal with UK firm
April 16, 2015Research and Development, Sales and Marketing AstraZeneca, IMCgp100, MEDI4736, MedImmune, Oxford, immuno-oncology, immunocore, melanoma, tremelimumab
UK pharma and biotech firms AstraZeneca and Immunocore are teaming up to launch early-stage studies of potential new cancer treatments. …
Immunocore appoints key scientist to board
March 31, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing immunocore, john bell
UK biotech Immunocore has appointed the Regius Professor of medicine at Oxford University and chairman of the office for the …
Immunocore names chief executive
January 14, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eliot Forster, immunocore
Oxford-based biotec Immunocore has announced the appointment of Dr Eliot Forster as its chief executive with immediate effect. Forster takes …
Lilly signs Immunocore deal
July 17, 2014Research and Development, Sales and Marketing Cancer, Oxford, biotech, immunocore, lilly
Eli Lilly has signed a deal with one of the UK’s most high-profile biotech firms to research and potentially develop …
Immunocore chief executive cements role at Adaptimmune
March 27, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adaptimmune, immunocore, noble
Biotech firm Adaptimmune has confirmed the full-time appointment of James Noble as its chief executive. Noble has been chief executive …
Immunocore promotes non-executive to chairman
November 19, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing immunocore, knowles
Oxford-based biotech firm Immunocore has appointed Dr Jonathan Knowles as the new executive chairman of its Board of directors. Knowles …
GSK teams up with Oxford biotech on cancer
July 9, 2013Research and Development, Sales and Marketing GSK, Oxford, immunocore
GlaxoSmithKline has announced a partnership with a UK biotech firm to develop oncology medicines using new methods to fight the …
